Impel neuropharma headquarters

Author: qsav

August undefined, 2024

Witryna22 kwi 2024 · At Impel Pharmaceuticals we are focused on developing and commercializing transformative therapies for people living with central nervous system … Witryna12 kwi 2024 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Impel Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for IMPL. The average twelve-month price prediction for Impel Pharmaceuticals is $21.25 with a high price target of $40.00 and a low price target of …

News Releases Impel Pharmaceuticals Inc.

WitrynaImpel Pharmaceuticals Inc. is a Seattle-based, commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high … Witryna(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Adrian Adams President and Chief Executive Officer … sharon astyk

Impel Neuropharma Announces FDA Submission Of New Drug …

WitrynaHeadquarters Regions Greater Seattle Area, West Coast, Western US Founded Date 2008 Founders John Hoekman, Michael Hite, Rodney Ho Operating Status Active Last Funding Type Post-IPO Debt Legal … WitrynaAbout us. Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet … Witryna11 kwi 2024 · Corporate Profile. Impel Pharmaceuticals is the first company to investigate targeting the upper nasal space with optimized therapeutic molecules … sharona stone lcsw

Impel Neuropharma Announces Company Will Now Be Known as

Witryna5 maj 2024 · Impel NeuroPharma, Inc., is a privately held, Seattle-based biopharmaceutical company which, based on the research of its founder, Chief … Witryna2 cze 2024 · Impel NeuroPharma, Inc. is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for people suffering from diseases with high unmet needs, with an initial focus on diseases of the CNS. The Company’s strategy is to rapidly advance its product … sharon astyk booksWitrynaImpel NeuroPharma. Sep 2024 - Present1 year 8 months. Salt Lake City, Utah, United States. Launch of a new migraine product with Impel, I cover the greater SLC territory and north up to Idaho ... sharon astyk twitter

"WitrynaDescription. Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize … " - Impel neuropharma headquarters

Impel neuropharma headquarters

WitrynaImpel Pharmaceuticals Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update. Trudhesa® Achieved nTRx of Over 58.4K in 2024; nTRx Increased by 19.4% in Q4 vs ... Witryna29 mar 2024 · The marks "IMPEL," "POD," "Trudhesa," "IMPELPOD" and the Impel NeuroPharma logo and our other registered or common law trade names, trademarks or service marks appearing in this report are the property of Impel. All other service marks, trademarks and trade names appearing in this report are the property of their …

Did you know?

WitrynaImpel Pharmaceuticals General Information. Description. Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the … WitrynaIMPEL NEUROPHARMA, INC. (Exact name of Registrant as specified in its charter) Delaware : 26-3058238 (State or other jurisdiction of ... (Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices) 2024 Equity Incentive Plan . 2024 Employee Stock Purchase Plan . 2024 Equity Incentive ...

Witryna10 lut 2024 · Impel NeuroPharma, Inc. is a privately held, Seattle-based biopharmaceutical company focused on developing transformative therapies for … Witryna12 kwi 2024 · Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2024. Show more Impel Pharmaceuticals Inc. …

Witryna22 lut 2024 · Impel NeuroPharma is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases. … WitrynaIMPEL NEUROPHARMA, INC. (Exact name of Registrant as specified in its charter) Delaware : 26-3058238 (State or other jurisdiction of ... (Address, including zip code, …

WitrynaFind real-time IMPL - Impel Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

Witryna6 sty 2024 · Impel NeuroPharma, Inc., is a privately-held, Seattle-based biotechnology company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel ... sharon a stokes md sharona sunshineWitryna11 lut 2024 · Impel adopting Veeva software, data, and consulting to accelerate pre-launch planning and digital-first commercial execution. SEATTLE and PLEASANTON, CA — February 10, 2024 — Impel NeuroPharma and Veeva Systems (NYSE: VEEV) today announced a strategic partnership as Impel continues advancing its pipeline of … population of rockbridge county vaWitryna7 lip 2024 · Impel NeuroPharma, Inc. is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative … population of robinvale victoriaWitrynaThis presentation and the accompanying oral commentary by Impel NeuroPharma, Inc. (“we,” “us,” “our,” “Impel” or the “Company”) contains forward-looking statements that … sharona stylesWitryna25 kwi 2024 · SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing … sharona s hillWitrynaImpel Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IMPL updated stock price target summary. sharona stone therapist colorado